Gero Secures $2.2 Million to Develop its AI Platform Further

The platform is also being utilized to develop drugs in other areas, such as finding potential therapies for COVID-19, including those that could reduce mortality from complications related to aging

FREMONT, CA: Gero, a Singapore-based company that develops new drugs for aging and other complicated disorders using its proprietary developed artificial intelligence (AI) platform, secured $2.2m in Series A funding. The latest funding brings the total capital raised to over $7.5m.

Bulba Ventures led the round with participation from previous investors and serial entrepreneurs in the fields of pharmaceuticals, IT, and AI. The co-founder of Bulba Ventures Yury Melnichek joined Gero’s Board of Directors.

Led by founder Peter Fedichev, the startup will use the new funds to further develop its AI platform for analyzing clinical and genetic data to identify treatments for chronic aging-related diseases, mental disorders, and other diseases.

The company’s experts use massive datasets of medical and genetic information from a large number of people acquired via biobanks and create a proprietary database of blood samples collected throughout the last 15 years of the patients’ lives. By utilizing this data, the platform determines the protein circulating in people’s blood, and upon removing or blocking should lead to rejuvenation. Subsequent experiments at the National University of Singapore involved aged animals, which showed mortality delay (life-extension) and functional improvements after a single experimental treatment. In the future, this new drug could enable patients to recover after a stroke and could enable cancer patients in their fight against accelerated aging resulting from chemotherapy.

The platform is currently also being utilized to develop drugs in other areas, such as finding potential therapies for COVID-19, including those that could reduce mortality from complications related to aging. It has already attracted a great deal of attention from large pharmaceutical companies and leading global media organizations.

Check Out: Top Big Data Companies in APAC